Meighan Parker

Meighan Parker joined the University of Georgia School of Law faculty in 2024 as an assistant professor. Parker’s scholarship lies at the intersection of health law, constitutional law and bioethics, examining the legal and ethical implications of novel digital health technologies designed to democratize access to healthcare. Her scholarship has been published in leading law reviews, including the North Carolina Law Review and the Columbia Science and Technology Law Review.  She also co-authored a chapter in Cybersecurity: A Practical Guide to the Law of Cyber Risk and an article in the Food and Drug Law Institute’s Update magazine titled, “Keeping Track of the Quacks: Drug and Device Enforcement in the COVID-19 Era.” 

Prior to joining the Law School, Parker was a Harry A. Bigelow Teaching Fellow and Lecturer in Law at the University of Chicago Law School, where she taught Legal Research & Writing. Before entering academia, Parker maintained a robust legal practice at Sidley Austin and Ropes & Gray, advising pharmaceutical and medical device companies on a broad range of regulatory and compliance matters under the Federal Food, Drug and Cosmetic Act and related laws. Her practice also included a legal secondment at Ginkgo Bioworks, where she worked closely with in-house counsel on regulatory compliance and transactional matters.

Parker earned her B.S. in biology cum laude from Spelman College and her Master of Theological Studies (focused on religion, ethics and politics) from the Harvard Divinity School. Afterward, she earned her J.D. cum laude from the University of Alabama School of Law, where she received the John England Award, served as captain of the Health Law Transactional Moot Court team, and worked as a spring extern in the Special Litigation Section of the U.S. Department of Justice Civil Rights Division.

Parker has been actively engaged in civic and alumni service. She has served on the Harvard Divinity School Alumni/Alumnae Council (AAC) since 2021 and the Harvard Alumni Association (HAA) Board of Directors since 2024.